Anacor Pharmaceuticals Inc.

Anacor Pharmaceuticals Inc. is developing a new class of antibiotics against a novel target discovered by its scientific founders. The company aims to create drugs that will address the growing problem of bacterial resistance to existing antibiotics, and also for use against biowarfare pathogens, such as anthrax, likely to be deployed in a bioterror attack.